Microbix Biosystems Inc. (MBXBF)
OTCMKTS
· Delayed Price · Currency is USD
0.2500
-0.0100 (-3.85%)
May 15, 2025, 1:11 PM EDT
Microbix Biosystems Revenue
Microbix Biosystems had revenue of 5.32M CAD in the quarter ending March 31, 2025, a decrease of -5.47%. This brings the company's revenue in the last twelve months to 22.72M, down -4.67% year-over-year. In the fiscal year ending September 30, 2024, Microbix Biosystems had annual revenue of 25.39M with 53.77% growth.
Revenue (ttm)
22.72M CAD
Revenue Growth
-4.67%
P/S Ratio
2.27
Revenue / Employee
227.22K CAD
Employees
100
Market Cap
36.29M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 25.39M | 8.88M | 53.77% |
Sep 30, 2023 | 16.51M | -2.56M | -13.43% |
Sep 30, 2022 | 19.08M | 483.28K | 2.60% |
Sep 30, 2021 | 18.59M | 8.07M | 76.66% |
Sep 30, 2020 | 10.52M | -2.89M | -21.53% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
Silence Therapeutics | 27.70M |
Microbix Biosystems News
- 2 days ago - Microbix & Aurevia Introduce Novel EQA Scheme - GlobeNewsWire
- 7 days ago - Microbix Schedules Release of Results for Q2 Fiscal 2025 - GlobeNewsWire
- 14 days ago - Microbix Presenting at the 2025 Bloom Burton Conference - GlobeNewsWire
- 5 weeks ago - Microbix Provides Business Updates - GlobeNewsWire
- 7 weeks ago - Microbix Announces Annual and Special Meeting Voting Results - GlobeNewsWire
- 7 weeks ago - Microbix Further Optimizes Capital Usage and Availability - GlobeNewsWire
- 2 months ago - Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific - GlobeNewsWire
- 3 months ago - Microbix Presenting at Investor Conference in B.C. - GlobeNewsWire